IPO market

Unlisted Ideas

Invest in Pre-IPO shares

IPO Ideas

Invest in IPO in just 3 clicks

Symbiotec Pharmalab IPO listing date & price

Q: What is the Symbiotec Pharmalab IPO allotment date?

The Symbiotec Pharmalab IPO allotment date is when the company finalizes share allocation to applicants. After allotment, you can check your status on the registrar's portal using your application number, PAN, or DP ID.

Q: Where can I check Symbiotec Pharmalab IPO allotment status?

You can check Symbiotec Pharmalab IPO allotment status on the registrar's website or the exchange portal once allotment is finalized. You will need your application number, PAN, or DP ID/Client ID to verify your allotment.

BBMainboardBSE, NSE

Latest GMPGMP Updated 16 hr ago

333 Seller

+33.70%

Symbiotec Pharmalab IPO is a Mainboard IPO. Issue size is ₹1,757 Cr. Price band is ₹938 to ₹988 per share. Minimum investment is ₹14,820. Lot size is 15 shares. Open from 24 Aug 2026 to 27 Aug 2026. on 28 Aug 2026. Listing on 1 Sept 2026 at BSE, NSE. Managed by JM Financial Ltd., Avendus Capital Pvt.Ltd., Motilal Oswal Investment Advisors Ltd., and Nomura Financial Advisory & Securities (India) Pvt.Ltd. Registrar: MUFG Intime India Private Limited (Link Intime). Key details for GMP, subscription, price, , and listing in one place.

Official documents:DRHP.

Follow the latest IPO & unlisted research on iOS and Android.

Google Play App Store

Symbiotec Pharmalab IPO listing date & price

BBMainboardBSE, NSE

Latest GMPGMP Updated 16 hr ago

333 Seller

+33.70%

Official documents:DRHP.

Symbiotec Pharmalab IPO — listing

Official listing price and performance versus the issue price, after the stock debuts on the exchange.

Listing data coming soon

Symbiotec Pharmalab IPO is not listed yet. Listing price and performance will appear here once available.

View GMP

Symbiotec Pharmalab IPO listing FAQs

How listing price and listing performance work.

What is the Symbiotec Pharmalab IPO listing price?

The Symbiotec Pharmalab IPO listing price is the price at which the company's shares are listed on the stock after the IPO process. It may be at a premium or discount to the issue price depending on market demand and sentiment.

When is the Symbiotec Pharmalab IPO listing date?

The Symbiotec Pharmalab IPO listing date is the date when the company's shares are listed on the stock exchanges (NSE/BSE) and become available for trading. It is usually announced after the process is completed.

What is the Symbiotec Pharmalab IPO allotment date?

The Symbiotec Pharmalab IPO date is when the company finalizes share allocation to applicants. After , you can check your status on the registrar's portal using your application number, PAN, or DP ID.

What is listing gain or loss in Symbiotec Pharmalab IPO?

Listing gain or loss is the difference between the listing price and the issue price. A positive listing gain means the share listed above the issue price; a loss means it listed below. Past listing performance does not guarantee future results.

Where can I check Symbiotec Pharmalab IPO allotment status?

You can check Symbiotec Pharmalab IPO status on the registrar's website or the portal once is finalized. You will need your application number, PAN, or DP ID/Client ID to verify your .

How is the Symbiotec Pharmalab IPO listing price determined?

The Symbiotec Pharmalab IPO listing price is determined by market demand and supply on the listing day. Factors include subscription response, company fundamentals, sector sentiment, and overall market conditions.

Can the Symbiotec Pharmalab IPO listing price differ from the issue price?

Yes, the Symbiotec Pharmalab IPO listing price can be different from the issue price. It may list at a premium (above issue price) or at a discount (below issue price) depending on market conditions at the time of listing.

How is listing performance calculated for Symbiotec Pharmalab IPO?

Listing performance for Symbiotec Pharmalab IPO is calculated as the percentage change from the issue price to the listing price. It is for informational purposes only and does not guarantee similar outcomes for other IPOs.